| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ALDER BIOPHARMACEUTICALS INC | 1,689,071 | 55,351,000 | 6.10% | ||
| 2 | NEVRO CORP | 491,044 | 51,260,000 | 5.65% | ||
| 3 | Theravance Biopharma Inc | 1,118,372 | 40,530,000 | 4.47% | ||
| 4 | MINERVA NEUROSCIENCES INC COM | 2,800,000 | 39,522,000 | 4.36% | ||
| 5 | PROTEOSTASIS THERAPEUTICS IN | 2,350,000 | 36,636,000 | 4.04% | ||
| 6 | Clearside Biomedical Inc | 1,988,208 | 34,496,000 | 3.80% | ||
| 7 | EAGLE PHARMACEUTICALS INC COM | 455,995 | 31,920,000 | 3.52% | ||
| 8 | HERON THERAPEUTICS INC | 1,771,263 | 30,519,000 | 3.37% | ||
| 9 | ARDELYX INC COM | 2,071,964 | 26,811,000 | 2.96% | ||
| 10 | MYOKARDIA INC | 1,605,790 | 26,239,000 | 2.89% | ||
| 11 | CLOVIS ONCOLOGY INC | 650,000 | 23,433,000 | 2.58% | ||
| 12 | ACLARIS THERAPEUTICS INC COM | 901,286 | 23,082,000 | 2.55% | ||
| 13 | QUOTIENT LTD | 2,787,717 | 21,800,000 | 2.40% | ||
| 14 | GALAPAGOS NV | 334,044 | 21,441,000 | 2.36% | ||
| 15 | MACROGENICS INC | 707,978 | 21,176,000 | 2.34% | ||
| 16 | NEUROCRINE BIOSCIE COM USD0.001 | 398,301 | 20,170,000 | 2.22% | ||
| 17 | OMEROS CORP | 1,695,000 | 18,916,000 | 2.09% | ||
| 18 | Protagonist Therapeutics, Inc. | 800,000 | 16,904,000 | 1.86% | ||
| 19 | WAVE LIFE SCIENCES LTD | 507,907 | 16,492,000 | 1.82% | ||
| 20 | SORRENTO THERAPEUTICS INC COM NEW | 2,121,013 | 16,417,000 | 1.81% | ||
| 21 | COHERUS BIOSCIENCES INC COM | 576,106 | 15,428,000 | 1.70% | ||
| 22 | CHINA BIOLOGIC PRODS INC | 112,867 | 14,050,000 | 1.55% | ||
| 23 | CORBUS PHARMACEUTICALS HLDGS COM | 2,000,000 | 13,580,000 | 1.50% | ||
| 24 | PORTOLA PHARMACEUTICALS INC | 596,000 | 13,535,000 | 1.49% | ||
| 25 | CELLECTIS S A | 498,117 | 11,995,000 | 1.32% | ||
| 26 | AGENUS INC | 1,578,106 | 11,331,000 | 1.25% | ||
| 27 | INVUITY INC | 767,466 | 10,530,000 | 1.16% | ||
| 28 | ADVAXIS INC COM NEW | 920,915 | 9,845,000 | 1.09% | ||
| 29 | GEMPHIRE THERAPEUTICS INC | 900,000 | 9,828,000 | 1.08% | ||
| 30 | CONTRAFECT CORP COM | 3,840,966 | 9,526,000 | 1.05% | ||
| 31 | INC Research Holdings Inc | 200,000 | 8,916,000 | 0.98% | ||
| 32 | BLUEPRINT MEDICINES CORP COM | 298,870 | 8,876,000 | 0.98% | ||
| 33 | COLLEGIUM PHARMACEUTICAL INC COM | 455,515 | 8,773,000 | 0.97% | ||
| 34 | DEXCOM | 100,000 | 8,766,000 | 0.97% | ||
| 35 | ALNYLAM PHARMACEUTICALS INC | 126,120 | 8,548,000 | 0.94% | ||
| 36 | ACHILLION PHARMACEUTICALS INC COM | 1,006,128 | 8,150,000 | 0.90% | ||
| 37 | Audentes Therapeutics, Inc. | 449,660 | 8,008,000 | 0.88% | ||
| 38 | EMERGENT BIOSOLUTIONS INC COM | 250,000 | 7,883,000 | 0.87% | ||
| 39 | ULTRAGENYX PHARMACEUTICAL INC COM | 110,842 | 7,863,000 | 0.87% | ||
| 40 | ARRAY BIOPHARMA INC COM | 1,150,000 | 7,763,000 | 0.86% | ||
| 41 | FULGENT GENETICS INC | 800,000 | 7,376,000 | 0.81% | ||
| 42 | FORWARD PHARMA A/S | 339,175 | 7,123,000 | 0.79% | ||
| 43 | SANGAMO BIOSCIENCES INCORPORATED | 1,402,331 | 6,493,000 | 0.72% | ||
| 44 | Curis, Inc | 2,410,900 | 6,292,000 | 0.69% | ||
| 45 | ZYNERBA PHARMACEUTICALS INC | 480,501 | 6,271,000 | 0.69% | ||
| 46 | SOCIETAL CDMO INC | 669,239 | 5,916,000 | 0.65% | ||
| 47 | CYTOMX THERAPEUTICS INC COM | 371,636 | 5,827,000 | 0.64% | ||
| 48 | DERMIRA INC | 172,083 | 5,820,000 | 0.64% | ||
| 49 | PFENEX INC COM | 632,559 | 5,661,000 | 0.62% | ||
| 50 | AVEXIS INC COM | 131,858 | 5,434,000 | 0.60% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001583977-16-000008, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
